[Federal Register Volume 83, Number 128 (Tuesday, July 3, 2018)]
[Notices]
[Page 31124]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-14290]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Charter Renewal of Department of Defense Federal Advisory 
Committees

AGENCY: Department of Defense.

ACTION: Renewal of federal advisory committee.

-----------------------------------------------------------------------

SUMMARY: The Department of Defense is publishing this notice to 
announce that it is renewing the charter for the Uniform Formulary 
Beneficiary Advisory Panel (``the Panel'').

FOR FURTHER INFORMATION CONTACT: Jim Freeman, Advisory Committee 
Management Officer for the Department of Defense, 703-692-5952.

SUPPLEMENTARY INFORMATION: The Panel's charter is being renewed 
pursuant to 10 U.S.C. 1074g(c)(1) and in accordance with the Federal 
Advisory Committee Act (FACA) of 1972 (5 U.S.C., Appendix, as amended) 
and 41 CFR 102-3.50(a). The Panel's charter and contact information for 
the Panel's Designated Federal Officer (DFO) can be found at http://www.facadatabase.gov/.
    The Panel provides the Secretary of Defense and the Deputy 
Secretary of Defense, through the Under Secretary for Personnel and 
Readiness, and the Assistant Secretary of Defense for Health Affairs, 
independent advice and recommendations on the development of the 
uniform formulary. The Secretary of Defense shall consider the comments 
of the Panel before implementing the uniform formulary or implementing 
changes to the uniform formulary.
    The Panel shall be composed of no more than 15 members and shall 
include members that represent: a. Non-governmental organizations and 
associations that represent the views and interests of a large number 
of eligible covered beneficiaries; b. Contractors responsible for the 
TRICARE retail pharmacy program; c. Contractors responsible for the 
national mail-order pharmacy program; and d. TRICARE network providers. 
All members of the Panel are appointed to provide advice on behalf of 
the Government on the basis of their best judgment without representing 
any particular point of view and in a manner that is free from conflict 
of interest. Except for reimbursement of official Panel-related travel 
and per diem, Panel members serve without compensation.
    The public or interested organizations may submit written 
statements to the Panel membership about the Panel's mission and 
functions. Written statements may be submitted at any time or in 
response to the stated agenda of planned meeting of the Panel. All 
written statements shall be submitted to the DFO for the Panel, and 
this individual will ensure that the written statements are provided to 
the membership for their consideration.

    Dated: June 28, 2018.
Shelly Finke,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2018-14290 Filed 7-2-18; 8:45 am]
 BILLING CODE 5001-06-P